Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

BUY
N/A
394 New
394 $0
Q2 2022

Aug 11, 2022

SELL
$2.22 - $6.7 $43,092 - $130,053
-19,411 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$4.18 - $13.39 $994 - $3,186
238 Added 1.24%
19,411 $120,000
Q4 2021

Feb 10, 2022

SELL
$11.35 - $97.17 $7,037 - $60,245
-620 Reduced 3.13%
19,173 $242,000
Q3 2021

Nov 12, 2021

BUY
$52.0 - $120.21 $42,744 - $98,812
822 Added 4.33%
19,793 $1.81 Million
Q2 2021

Aug 05, 2021

BUY
$31.88 - $58.66 $22,857 - $42,059
717 Added 3.93%
18,971 $1.01 Million
Q1 2021

May 06, 2021

SELL
$28.6 - $49.21 $31,374 - $53,983
-1,097 Reduced 5.67%
18,254 $658,000
Q4 2020

Feb 10, 2021

BUY
$27.78 - $56.93 $30,891 - $63,306
1,112 Added 6.1%
19,351 $538,000
Q3 2020

Nov 12, 2020

SELL
$39.85 - $57.3 $95,640 - $137,520
-2,400 Reduced 11.63%
18,239 $912,000
Q2 2020

Aug 13, 2020

BUY
$34.93 - $57.75 $244,440 - $404,134
6,998 Added 51.3%
20,639 $956,000
Q1 2020

May 06, 2020

BUY
$29.01 - $72.51 $74,555 - $186,350
2,570 Added 23.21%
13,641 $622,000
Q4 2019

Feb 05, 2020

BUY
$20.77 - $68.91 $229,944 - $762,902
11,071 New
11,071 $622,000

Others Institutions Holding CRTX

About Cortexyme, Inc.


  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.